Structural MRI substrate of long-duration response to levodopa in Parkinson’s disease: an exploratory study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Structural MRI substrate of long-duration response to levodopa in Parkinson’s disease: an exploratory study ; day:17 ; month:4 ; year:2021 ; pages:1-7
Journal of neurology ; (17.4.2021), 1-7
- Creator
-
Donzuso, Giulia
Sciacca, Giorgia
Rascunà, Cristina
Cicero, Calogero E.
Mostile, Giovanni
Nicoletti, Alessandra
Zappia, Mario
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-021-10550-5
- URN
-
urn:nbn:de:101:1-2021060510555901143642
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Donzuso, Giulia
- Sciacca, Giorgia
- Rascunà, Cristina
- Cicero, Calogero E.
- Mostile, Giovanni
- Nicoletti, Alessandra
- Zappia, Mario
- SpringerLink (Online service)
Other Objects (12)
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease